I wonder if we should ask Slater and Gordon, probably a good case separately for shareholders to have ago at GSK, to recover lost funds. Breach of contract, and Trade Practices issues abound here. Separate case against GSK from BTA's case I am thinking about it Slater and Gordon will take on almost anything if they reckon they can win, and it would be a huge case.
On the other hand look at the adverse publicity that GSK will receive, who will trust them again with a contract after this example.
opionions welcome cheers
BTA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held